Φορτώνει......
A 6-week, double-blind, placebo- and haloperidol-controlled, phase II study of lurasidone in patients with acute schizophrenia
OBJECTIVE: The objective of this study was to evaluate the short-term efficacy and safety of the atypical antipsychotic agent lurasidone in the treatment of schizophrenia. METHODS: In this phase II, randomized, double-blind, placebo-controlled study, hospitalized adult patients diagnosed with schizo...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Ther Adv Psychopharmacol |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
SAGE Publications
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4722503/ https://ncbi.nlm.nih.gov/pubmed/26834965 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125315606027 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|